About
Copy Link
Titles
Clinical Associate
Biography
Hematology Fellow, Yale University
Yale New Haven Hospital Internal Medicine Residency (2023- 2026)
Former Postdoctoral Associate, Hematology, Yale Cancer Center (2021-2023)
Postdoctoral advisor: Alfred Ian Lee MD PhD
Research Interests: Thrombosis, Hemostasis, Decision Science, Cost effectiveness studies, Medical education, Antiphospholipid syndrome
Last Updated on September 18, 2026.
Departments & Organizations
Education & Training
- MBBS
- Aga Khan University (2021)
Research
Copy Link
Overview
Medical Research Interests
Hematology; Internal Medicine
ORCID
0000-0003-1172-2159
Research at a Glance
Yale Co-Authors
Frequent collaborators of Ayesha Butt's published research.
Publications Timeline
A big-picture view of Ayesha Butt's research output by year.
Research Interests
Research topics Ayesha Butt is interested in exploring.
Alfred Lee, MD, PhD
Alexander B. Pine, MD, PhD
Anish Sharda, MD, MPH
Christopher Tormey, MD
Satoko Ito, MD, PhD
Sean Gu, MD, PhD
25Publications
146Citations
Hematology
Publications
Featured Publications
Bias Against International Medical Graduates in the Hematology/Oncology Fellowship Recruitment Process: Findings From a Nationwide Survey of Fellowship Program Directors
Butt A, Mankbadi M, Erikson C, Marshall A, Masselink LE, Tong G, Hafler J, Podoltsev N, Lee AI. Bias Against International Medical Graduates in the Hematology/Oncology Fellowship Recruitment Process: Findings From a Nationwide Survey of Fellowship Program Directors. JCO Oncology Practice 2022, 18: 783-787. PMID: 36108253, DOI: 10.1200/op.22.00219.Commentaries, Editorials and LettersCitationsAltmetric
2026
Correction: A proteomic map of thromboinflammatory signatures in antiphospholipid syndrome: results from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) registry
Pine A, Butt A, Andreoli L, Knight J, Gerosa M, Cecchi I, Branch D, Lopez-Pedrera R, Belmont H, Kello N, Petri M, Cervera R, Pengo V, Meroni P, Cohen H, Willis R, Bertolaccini M, Goshua G, Gu S, Hwa J, Lee A, Erkan D, Sharda A. Correction: A proteomic map of thromboinflammatory signatures in antiphospholipid syndrome: results from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) registry. Frontiers In Immunology 2026, 17: 1807468. PMID: 42039181, PMCID: PMC13107004, DOI: 10.3389/fimmu.2026.1807468.Commentaries, Editorials and LettersCitations
2025
A proteomic map of thromboinflammatory signatures in antiphospholipid syndrome: results from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) registry
Pine A, Butt A, Andreoli L, Knight J, Gerosa M, Cecchi I, Branch D, Lopez-Pedrera R, Belmont H, Kello N, Petri M, Cervera R, Pengo V, Meroni P, Cohen H, Willis R, Bertolaccini M, Goshua G, Gu S, Hwa J, Lee A, Erkan D, Sharda A. A proteomic map of thromboinflammatory signatures in antiphospholipid syndrome: results from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) registry. Frontiers In Immunology 2025, 16: 1676578. PMID: 41181143, PMCID: PMC12571811, DOI: 10.3389/fimmu.2025.1676578.Peer-Reviewed Original ResearchCitationsAltmetricAnalytical Review: Neutrophil Extracellular Traps and Antiphospholipid syndrome
Butt A, Sharda A, Lee A, Knight J. Analytical Review: Neutrophil Extracellular Traps and Antiphospholipid syndrome. Transfusion Medicine Reviews 2025, 40: 150909. PMID: 40783311, DOI: 10.1016/j.tmrv.2025.150909.Peer-Reviewed Original ResearchCitationsAltmetricInternational Medical Graduates Representation at International Oncology Conference Meetings: An Analysis of ASCO Annual Meetings
Roy A, Bakouny Z, Paul M, Ozay Z, Lal B, Nawfal R, Eid M, Chehade R, Machaalani M, Butt A, Aggarwal C, Bekaii-Saab T, Chavez-MacGregor M, Lopes G, Marshall A, Murphy M, Owonikoko T, Xie W, Lee A, Choueiri T. International Medical Graduates Representation at International Oncology Conference Meetings: An Analysis of ASCO Annual Meetings. JCO Oncology Practice 2025, 22: 708-716. PMID: 40577682, PMCID: PMC13472533, DOI: 10.1200/op-25-00067.Peer-Reviewed Original ResearchCitationsAltmetric
2024
Guide to Understanding and Supporting International Medical Graduates in Hematology/Oncology by the ASCO International Medical Graduates Community of Practice
Bakouny Z, Haykal T, Riano I, Desai A, Butt A, Basu A, Zhao D, Saad E, Saliby R, Gosain R, Gosain R, Ardeshir F, Deng L, Matt-Amaral L, Arnaoutakis K, Bekaii-Saab T, Manochakian R, Marshall A, Forde P, Murphy M, Subbiah V, Chavez-MacGregor M, Owonikoko T, Lopes G, Aggarwal C, Lee A, Choueiri T. Guide to Understanding and Supporting International Medical Graduates in Hematology/Oncology by the ASCO International Medical Graduates Community of Practice. JCO Oncology Practice 2024, 21: 292-299. PMID: 39374449, PMCID: PMC12455576, DOI: 10.1200/op-24-00565.Peer-Reviewed Original ResearchCitationsAltmetricPhenotypic and genotypic evaluation of bleeding diagnostic dilemmas: Two case studies
Gu S, Butt A, Schulz V, Rinder H, Lee A, Gallagher P, Hwa J, Bona R. Phenotypic and genotypic evaluation of bleeding diagnostic dilemmas: Two case studies. Blood Cells Molecules And Diseases 2024, 110: 102893. PMID: 39260211, DOI: 10.1016/j.bcmd.2024.102893.Peer-Reviewed Original ResearchCitationsFactor VIII Levels and ISTH Disseminated Intravascular Coagulation Scores Do Not Distinguish Disseminated Intravascular Coagulation from the Coagulopathy of Liver Disease
Heskel M, Butt A, Tormey C, Pine A, Lee A, Gautam S. Factor VIII Levels and ISTH Disseminated Intravascular Coagulation Scores Do Not Distinguish Disseminated Intravascular Coagulation from the Coagulopathy of Liver Disease. Acta Haematologica 2024, 148: 220-225. PMID: 39004080, PMCID: PMC12106121, DOI: 10.1159/000540239.Peer-Reviewed Original ResearchCitationsCost-effectiveness of bevacizumab therapy in the care of patients with hereditary hemorrhagic telangiectasia
Wang D, Ito S, Waldron C, Butt A, Zhang E, Krumholz H, Al-Samkari H, Goshua G. Cost-effectiveness of bevacizumab therapy in the care of patients with hereditary hemorrhagic telangiectasia. Blood Advances 2024, 8: 2835-2845. PMID: 38537061, PMCID: PMC11176968, DOI: 10.1182/bloodadvances.2024012589.Peer-Reviewed Original ResearchCitationsAltmetricCost-effectiveness of rapid vs in-house vs send-out ADAMTS13 testing for immune thrombotic thrombocytopenic purpura
Ito S, Butt A, Purcell A, Richmond R, Tormey C, Krumholz H, Cuker A, Goshua G. Cost-effectiveness of rapid vs in-house vs send-out ADAMTS13 testing for immune thrombotic thrombocytopenic purpura. Blood Advances 2024, 8: 2279-2289. PMID: 38502197, PMCID: PMC11116991, DOI: 10.1182/bloodadvances.2024012608.Peer-Reviewed Original ResearchCitationsAltmetric
Academic Achievements & Community Involvement
Copy Link
Activities
activity JCO Oncology Practice
10/01/2022 - PresentPeer Review Groups and Grant Study SectionsReviewerDetailsPeer Reviewer
Honors
honor HTRS / Genentech "Best of ASH 2022"
12/11/2022Other AwardHemostasis and Thrombosis Research Society (HTRS)DetailsUnited Stateshonor Abstract selected for Highlights of ASH
12/11/2022Other AwardAmerican Society of HematologyDetailsUnited Stateshonor Abstract Achievement Award 2022
10/21/2022Other AwardAmerican Society of Hematology (ASH)DetailsUnited Stateshonor Young Investigator Travel Award
08/01/2022Other AwardThrombosis & Hemostasis Summit of North America (THSNA)DetailsUnited States
News
Copy Link
News
Get In Touch
Copy Link
Contacts
Email